1-3 of 3
Peter Huijgens, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission

Edo Vellenga, MD, PhD, Wim van Putten, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Martin Fey, MD, Jurgen Kuball, MD, PhD, Matthias Theobald, MD, PhD, Jan J. Cornelissen, MD, PhD, Peter Huijgens, MD, PhD, Johan Maertens, Alois Gratwohl, MD, Martyn Ronald Schaafsma, MD, PhD, Markus G Manz, MD, Carlos Graux, MD, PhD, Bob Lowenberg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 367.
https://doi.org/10.1182/blood.V116.21.367.367
Published: 2010
Journal Articles

No Harmful Impact of 90Yttrium-Ibritumomab Tiuxetan Combined with BEAM On Bone Marrow Microenvironment.

Otto Visser, MD, Floortje Kessler, Lars Perk, Maria Vosjan, Guus van Dongen, Josée Zijlstra, MD, PhD, Peter Huijgens, MD, PhD, Sonja Zweegman, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3538.
https://doi.org/10.1182/blood.V114.22.3538.3538
Published: 2009
Journal Articles

Intensified CHOP with Rituximab for Intermediate or High-Risk Non-Hodgkin’s Lymphoma: Interim Analysis of a Randomized Phase III Trial in Elderly Patients by the Dutch HOVON and Nordic Lymphoma Groups.

Pieter Sonneveld, MD, Wim van Putten, MSc, Harald Holte, MD, Douwe Biesma, MD, Marinus van Marwijk-Kooy, MD, Mark Kramer, MD, Pierre Wijermans, MD, Monique Steijaert, Peter Huijgens, MD, Mikael Eriksson, MD
Journal: Blood
Blood (2005) 106 (11): 16.
https://doi.org/10.1182/blood.V106.11.16.16
Published: 2005